Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease:
a prospective randomised trial
To access this article, please choose from the options below
PII: S0959-8049(01)00198-8
© 2001 Elsevier Science Ltd. All rights reserved.
